Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris
Anton Camaj(Columbia University Irving Medical Center), Roxana Mehran(Mount Sinai Hospital), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Annapoorna Kini(Mount Sinai Medical Center), Hanbo Qiu(Cardiovascular Institute of the South), Samin K. Sharma(Mount Sinai Health System), Nikola Kocovic(Cardiovascular Institute of the South), David Power(Cardiovascular Institute of the South), Gennaro Giustino(Cardiovascular Institute of the South), George Dangas(Mount Sinai Hospital), Nitin Barman(Icahn School of Medicine at Mount Sinai), Joseph Sweeny(Mount Sinai Hospital), Tomoya Hinohara(Houston Methodist), Zhongjie Zhang(Shanxi Medical University), Usman Baber(Icahn School of Medicine at Mount Sinai), Davide Cao(Cardiovascular Institute of the South), Johny Nicolas(Cardiovascular Institute of the South), Bimmer E. Claessen(Columbia University Irving Medical Center)
Cited by 6
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k